Publications

  1. Asiri IM, Chen RC, Master V, Mi L, James SE, Odedina FT, Bryce AH, Tilburt JC, Riaz IB, Naqvi SAA, Abraham V, Beach SRH, Cobran EK. Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients. Cancer Epidemiol. 2025 Apr; 95:102769 Epub 2025 Feb 12
    View PubMed
  2. Yap JQ, Riggan KA, Cobran EK, Halyard MY, James SE, Kelly MK, Phillips DT, Allyse MA. Psychological Safety in the Medical Care of Black Breast and Ovarian Cancer Patients and Families. Psychooncology. 2025 Mar; 34 (3):e70127
    View PubMed
  3. James SE, Riggan KA, Halyard M, Kelly M, Cobran E, Allyse MA. The "Strong Black Woman" Paradox: Insights from a Cohort of Black Breast and Ovarian Cancer Patients and Family Members. J Racial Ethn Health Disparities. 2025 Feb; 12 (1):659-665 Epub 2024 Jan 08
    View PubMed
  4. Naqvi SAA, Riaz IB, Bibi A, Khan MA, Imran M, Khakwani KZR, Raina A, Anjum MU, Cobran EK, Warner JL, Hussain SA, Singh P, Childs DS, Baca SC, Orme JJ, Mateo J, Agarwal N, Gillessen S, Murad MH, Sartor O, Bryce AH. Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis. Eur Urol. 2025 Jan 22 [Epub ahead of print]
    View PubMed
  5. Schaid DJ, McDonnell SK, Akhtari FS, Sinnwell JP, Batzler A, Cobran EK, Motsinger-Reif A. Polygenic scores and social determinants of health: Their correlations and potential biases. HGG Adv. 2025 Jan 9; 6 (1):100389 Epub 2024 Nov 27
    View PubMed
  6. Bryant AL, Krok-Schoen JL, Cobran EK, Greer JA, Temel JS, Pirl WF. Evaluation of an intensive workshop on research methods in supportive oncology. Palliat Support Care. 2024 Aug; 22 (4):649-654
    View PubMed
  7. Ali AM, Cobran EK, Young HN. Individual, interpersonal, and community factors associated with health outcomes in patients with type 2 diabetes mellitus treated at federally qualified health centers. J Diabetes Metab Disord. 2024 Jun; 23 (1):1071-1080 Epub 2024 Feb 14
    View PubMed
  8. Rawal S, Osae SP, Cobran EK, Albert A, Young HN. Pharmacists' naloxone services beyond community pharmacy settings: A systematic review. Res Social Adm Pharm. 2023 Feb; 19 (2):243-265 Epub 2022 Sept 15
    View PubMed
  9. Asiri IM, Chen RC, Young HN, Codling J, Mandawat A, Beach SRH, Master V, Rajbhandari-Thapa J, Cobran EK. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer. Prostate Cancer Prostatic Dis. 2021 Dec; 24 (4):1093-1102 Epub 2021 May 03
    View PubMed
  10. Montiel Ishino FA, Rowan C, Das R, Thapa J, Cobran E, Whiteside M, Williams F. Identifying Risk Profiles of Malignant Prostate Cancer Surgical Delay Using a Person-Centered Approach to Understand Prostate Cancer Disparities: The Constellation of Health Determinants Using Latent Class Analysis on Cancer Registry Data. Am J Mens Health. 2020 Nov-Dec; 14 (6):1557988320984282
    View PubMed
  11. Cobran EK, Young HN, Chen RC, Chen X, Reeves J, Godley PA, Shah S. Race and Timing of Androgen Deprivation Therapy among Men with Metastatic Prostate Cancer. Journal of the National Medical Association. 2019; S0027-9684(18):30168-8.
  12. Alwhaibi A, Kolhe R, Gao F, Cobran EK, Somanath PR. Genome Atlas Analysis based Profiling of Akt Pathway Genes in the Early and Advanced Human Prostate Cancer. Oncoscience. 2019; 6(5-6):317-36.
  13. Shah S, Young HN, Cobran EK. Comparative Effectiveness of Conservative Management Compared to Cryotherapy in Localized Prostate Cancer Patients. Am J Mens Health. 2018 Sep; 12 (5):1681-1691 Epub 2018 June 07
    View PubMed
  14. Shah S, Cobran EK, Young H. An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer. Journal of Pharmaceutical Health Services Research. 2018.
  15. Shah S, Wei H, Jayawardhana J, Perri M, Cobran EK, Young H. Cost utility analysis of Methylphenidate and Amphetamine/Dexamphetamine in adults with Attention-deficit hyperactivity disorder. Journal of Pharmaceutical Health Services Research. 2017.
  16. Cobran EK, Merino Y, Roach B, Bigelow SM, Godley PA. A feasibility study of the independent specialty medical advocate model of patient navigation on intermediate health outcomes in newly diagnosed cancer patients. Journal of Oncology Navigation & Survivorship. 2017; 8(10):462-70.
  17. Cobran EK, Hall JN, & Aiken W. African-American and Caribbean-born men’s perceptions of prostate cancer fear and facilitators for screening behavior: A pilot study. Journal of Cancer Education. 2017.
  18. Cobran EK, Chen RC, Overman R, Meyer AM, Kuo TM, O'Brien J, Sturmer T, Sheets NC, Goldin GH, Penn DC, Godley PA, Carpenter WR. Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. Am J Mens Health. 2016 Sep; 10 (5):399-407 Epub 2015 Feb 05
    View PubMed
  19. Pen D, Stitzenberg K, Cobran EK, Godley PA. Provider-based Research Network Demonstrate Greater Hospice Use for Minority Patients with Lung Cancer J Oncol Pract. 2014; 10(4):182-90.
  20. Cobran EK, Wutoh AK, Lee E, Odedina F, Ragin C, Aiken W, Godley P. Perceptions of Prostate Cancer Fatalism and Screening Behavior Between United States-born and Caribbean-born Black Males J Immigr Minor Health. 2014; 16(3):394-400.
  21. Wutoh AK, Nichols-English G, Daniel M, Kendall KA, Cobran EK, et al. Pilot Study to Assess HIV Knowledge Spirituality, and Risk Behaviors Among Older African Americans J Natl Med Assoc. 2011; 103:265-8.